Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Orexo Logo

Orexo

Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but it is also our aim to address other therapeutic areas where our competence and technologies can create value. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercialize the product Zubsolv®. Other products are commercialized through partners, including sale of Zubsolv outside the US.

Get in touch with us!

Visit us

Rapsgatan 7e, Uppsala, Sweden

Send us mail

Orexo ABP.O. Box 303751 05 UppsalaSweden

Our published articles

No items found.
Date
Title
Category
No articles found.
Orexo

Orexo

Orexo develops improved pharmaceuticals based on innovative drug delivery technologies. The focus is primarily on opioid dependence and pain but it is also our aim to address other therapeutic areas where our competence and technologies can create value. The main market today is the American market for buprenorphine/naloxone products, where Orexo commercialize the product Zubsolv®. Other products are commercialized through partners, including sale of Zubsolv outside the US.

Get in touch with us!

Visit us

Rapsgatan 7e, Uppsala, Sweden

Send us mail

Orexo ABP.O. Box 303751 05 UppsalaSweden

Our published articles

No items found.
Date
Title
Category
No articles found.